about
KASL clinical practice guidelines: management of hepatitis CManagement of chronic hepatitis C virus infection in patients with end-stage renal disease: a reviewHepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variantsInterferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.Acute hepatitis C infection in a renal transplant recipient: primacy of the liver or kidney?Hepatitis C virus associated glomerulopathies.Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients.Management of the kidney transplant patient with chronic hepatitis C infectionRelevance of low viral load in haemodialysed patients with chronic hepatitis C virus infectionSASLT practice guidelines: management of hepatitis C virus infection.Viral-host interaction in kidney reveals strategies to escape host immunity and persistently shed virus to the urine.Safety and efficacy of elbasvir and grazoprevir for treatment of hepatitis C.Hepatitis C Virus Infection in Chronic Kidney Disease.Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease.Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus.Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report.Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population.Post-transfusion-transmitted hepatitis C virus infection: a study on thalassemia and hemodialysis patients in southeastern Iran.Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy.Hepatitis C infection in renal transplantation: pathogenesis, current impact and emerging trends.Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.KASL clinical practice guidelines: management of hepatitis C.2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
P2860
Q26752471-5F3D0650-A0D5-4B56-B1BD-510C33197E8DQ26821786-CEFC96D1-C5BD-4E70-99F5-70EC8A5F917AQ28482260-0283B269-355C-4E16-8CFD-37DDC6962985Q31155562-BC72B038-9916-45A2-876B-AE873AB1BF0DQ33743914-10C3B768-98F3-4A92-9853-40F2F9FC61A4Q33801278-463F155F-D5BA-4AB3-B629-2D69A2C87DC0Q34926896-21EF4970-35EF-43BA-BA93-E7777E483D3BQ34988932-1E575EE1-5DD8-4325-A2D6-BD55DE405485Q35594196-C9C01A14-AC95-4F5F-A3D4-EC01AF834FF6Q37019765-A407A74E-A527-4CC6-8599-2B8E8827F13AQ37702518-345608C6-C544-4391-8861-B4013AAC8937Q38811486-6FE975C1-F233-420E-97B6-5B1949A368DDQ38812607-3E8892C0-4D5B-43CA-A6DA-3106347B1A3BQ39455853-7DF7A91A-3B30-4BE1-83C7-E557C25EE3A5Q40278746-19F9A75D-439C-40B3-A598-429ABF97DE29Q40316547-A6D470AE-9F53-4763-B074-14591B665764Q40793177-E44B1443-14B2-4AA8-AE0A-914802F83196Q41977560-D321424A-1AF9-4E56-817F-88EDEE6C6D7BQ42223532-C1A6E33C-83A0-4E7F-96AE-CDFD60B9CE3DQ42997619-4C7AC5AD-8266-4BAD-B573-E007AFDC1B27Q43034552-76572BF2-332A-49A3-A53D-D381ECCD47D3Q45363707-B0DEFAA5-FD65-4AA0-A26D-5408DC479CE8Q47559302-2E7F1FDF-7956-4FFD-AC98-67D5A28CCF34Q48112497-78C3F33A-446B-4D76-A971-DC83509FFC08Q50556069-F4F5DB03-A4CE-45A9-BD25-3D6881F47926Q51836024-54D7387C-9252-482C-A271-FE424408A030Q58788714-6934138D-31E1-43B0-BC09-63056E848820
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis C virus and kidney disease.
@en
Hepatitis C virus and kidney disease.
@nl
type
label
Hepatitis C virus and kidney disease.
@en
Hepatitis C virus and kidney disease.
@nl
prefLabel
Hepatitis C virus and kidney disease.
@en
Hepatitis C virus and kidney disease.
@nl
P1476
Hepatitis C virus and kidney disease.
@en
P2093
Fabrizio Fabrizi
Paul Martin
P304
P356
10.1016/J.JHEP.2008.06.003
P577
2008-06-26T00:00:00Z